FAIRFAX, Va.Interventional radiologistsminimally invasive specialistswill share scientific advances and new discoveries in treating a host of diseases at the Society of Interventional Radiology's 35th Annual Scientific Meeting March 13 at the Tampa Convention Center, Tampa, Fla. This year's meeting theme is "IR Innovation"one that celebrates the remarkable inventiveness of interventional radiologists.
More than 5,000 physicians, scientists and allied health professionals are expected to attend this premier IR event. Hot topic main sessions include a look at practicing interventional radiology in extreme situations (wars, pandemics and natural catastrophes); IR frontiers (molecular medicine and nanotechnology); vertebral augmentation (past, present and future treatments); and future interventional oncology advances. A new categorical course will examine the most controversial interventional radiologyrelated studies of the past yearincluding critical review of the latest advances along with pro and con arguments. Topics that will be explored include vertebroplasty, stroke and yttrium-90 cancer treatments.
Central to the meeting's theme will be the presentation of painstakingly researched data on how prolific IRs have been as inventors and the impact their innovations have had in advancing patient care and building the specialty. This researchconducted during an exhaustive search of patent filings and applications at the PCT (Patent Cooperation Treaty) and the U.S. Patent and Trademark Officewill be honored with a special "Hall of Innovation."
Some of the exciting topics that will be featured at this year's press conferences include minimally invasive advances coming for liver, breast, soft tissue, prostate, lung and pancreatic cancers; spine fracture treatment (vertebroplasty) for osteoporotic and non-osteoporotic patients; women's health (uterine fibroid embolization and pregnancy; sound wavezapping treatment for uterine fibroids); getting to the heart of stroke with carotid stenting; another surprising look at Framingham risk scores; and stem cell therapy and stenting advances for peripheral arterial disease.
Plenary sessions include
|Contact: Maryann Verrillo|
Society of Interventional Radiology